Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Orosomucoid (ORM) is an acute-phase protein that belongs to the immunocalin subfamily, a group of small-molecule-binding proteins with immunomodulatory functions. Little is known about the role of ORM proteins in the CNS. The aim of the present study was to investigate the brain expression of ORM and its role in neuroinflammation. Expression of Orm2, but not Orm1 or Orm3, was highly induced in the mouse brain after systemic injection of lipopolysaccharide (LPS). Plasma levels of ORM2 were also significantly higher in patients with cognitive impairment than in normal subjects. RT-PCR, Western blot, and immunofluorescence analyses revealed that astrocytes are the major cellular sources of ORM2 in the inflamed mouse brain. Recombinant ORM2 protein treatment decreased microglial production of proinflammatory mediators and reduced microglia-mediated neurotoxicity in vitro. LPS-induced microglial activation, proinflammatory cytokines in hippocampus, and neuroinflammation-associated cognitive deficits also decreased as a result of intracerebroventricular injection of recombinant ORM2 protein in vivo. Moreover, lentiviral shRNA-mediated Orm2 knockdown enhanced LPS-induced proinflammatory cytokine gene expression and microglial activation in the hippocampus. Mechanistically, ORM2 inhibited C-C chemokine ligand 4 (CCL4)-induced microglial migration and activation by blocking the interaction of CCL4 with C-C chemokine receptor type 5. Together, the results from our cultured glial cells, mouse neuroinflammation model, and patient studies suggest that ORM2 is a novel mediator of astrocyte–microglial interaction. We also report that ORM2 exerts anti-inflammatory effects by modulating microglial activation and migration during brain inflammation. ORM2 can be exploited therapeutically for the treatment of neuroinflammatory diseases. SIGNIFICANCE STATEMENT Neural cell interactions are important for brain physiology and pathology. Particularly, the interaction between non-neuronal cells plays a central role in regulating brain inflammation, which is closely linked to many brain disorders. Here, we newly identified orosomucoid-2 (ORM2) as an endogenous protein that mediates such non-neuronal glial cell interactions. Based on the critical role of astrocyte-derived ORM2 in modulating microglia-mediated neuroinflammation, ORM2 can be exploited for the diagnosis, prevention, or treatment of devastating brain disorders that have a strong neuroinflammatory component, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 2×
“…studies, astrocytes were shown to modulate microglial activity through several astrocyte-derived factors, such as ATP, Ca2 , cytokines, chemokines, and other inflammatory mediators (Verderio and Matteoli, 2001; Schipke et al., 2002; Davalos et al., 2005; Tanuma et al., 2006; Jeon et al., 2012).”
BackgroundSelf-citationMicroglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 3×
“…strong neuroinflammatory component, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple sclerosis. ing and releasing reactive oxygen species, cytokines, and growth factors in response to neural injury (Hanisch and Kettenmann, 2007; Kettenmann et al., 2011).”
BackgroundKettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · cited 1×
“…strong neuroinflammatory component, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple sclerosis. ing and releasing reactive oxygen species, cytokines, and growth factors in response to neural injury (Hanisch and Kettenmann, 2007; Kettenmann et al., 2011).”
BackgroundSystemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“Neuroinflammation model based on intraperitoneal LPS injection A systemic injection of LPS was performed to evoke neuroinflammation in mice, as described previously (Qin et al., 2007).”
MethodTripartite synapses: astrocytes process and control synaptic information
Perea, G., Navarrete, M., & Araque, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.001 · Cited by 1,820 · cited 3×
“…including glutamate, GABA, purines (adenosine and ATP), and D-serine (Nedergaard et al., 2003; Halassa et al., 2007; Shigetomi et al., 2008; Perea et al., 2009); (3) promotion of myelinating activity of oligodendrocytes by secreting leukemia inhibitory factor, a regulatory protein that…”
BackgroundEichenbaum (2004) · doi:10.1016/j.neuron.2004.08.028 · Cited by 1,464
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
New roles for astrocytes: redefining the functional architecture of the brain.
Nedergaard, M., Ransom, B., & Goldman, S. A. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.008 · Cited by 1,334 · cited 3×
“, 2007; Iadecola and Nedergaard, 2007); (2) modulation of synaptic transmission through the regulated release of synaptically active molecules, including glutamate, GABA, purines (adenosine and ATP), and D-serine (Nedergaard et al., 2003; Halassa et al., 2007; Shigetomi et al., 2008; Perea et al., 2009); (3) promotion…”
BackgroundThe role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272 · cited 1×
“…diseases and other CNS disorders, including multiple sclerosis, stroke, traumatic brain injury, Parkinson’s disease, and Alzheimer’s disease (AD) (Akiyama et al., 2000; MorgantiKossmann et al., 2001; Lucas et al., 2006; Wang et al., 2007; Frischer et al., 2009; Tufekci et al., 2012).”
Background
Research works printed but not linked: 53
- 10.1042/bj3560121 · doi:10.1042/bj3560121
- 10.1186/1471-2377-5-22 · DOI
- 10.1007/BF00494364 · doi:10.1007/bf00494364
- 10.1007/BF00915815 · doi:10.1007/bf00915815
- 10.1038/npp.2014.199 · DOI
- 10.1189/jlb.0908551 · DOI
- 10.1016/j.jns.2011.03.023 · DOI
- 10.1096/fj.07-9411com · DOI · Paper page
- 10.3390/brainsci3031109 · DOI · Paper page
- Costello, 1984, Inhibition of neutrophil activation by alpha1-acid glycoprotein, Clin Exp Immunol, 55, 465
- Daveau, 1994, IL-6-induced changes in synthesis of alpha 1-acid glycoprotein in human hepatoma Hep3B cells are distinctively regulated by monoclonal antibodies directed against different epitopes of IL-6 receptor (gp80), Eur Cytokine Netw, 5, 601
- 10.2174/092986707780597961 · DOI · Paper page
- 10.1001/archneur.1976.00500100002003 · DOI
- Elg, 1997, Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma, Cancer, 80, 1448, 10.1002/(SICI)1097-0142(19971015)80:8<1448::AID-CNCR12>3.0.CO;2-5 · doi:10.1002/(sici)1097-0142(19971015)80:8<1448::aid-cncr12>3.0.co;2-5
- 10.1016/S0167-4838(00)00153-9 · DOI · Paper page
- Frautschy, 1998, Microglial response to amyloid plaques in APPsw transgenic mice, Am J Pathol, 152, 307
- 10.1002/glia.20543 · DOI · Paper page
- 10.1046/j.1471-4159.2003.01609.x · DOI
- 10.1016/j.bbagen.2005.03.012 · DOI
- 10.1155/2012/475153 · DOI
- 10.1016/j.brainresbull.2016.03.017 · DOI
- 10.1186/1742-2094-9-149 · DOI · Paper page
- 10.1186/1742-2094-9-207 · DOI · Paper page
- Kremer, 1988, Drug binding to human alpha-1-acid glycoprotein in health and disease, Pharmacol Rev, 40, 1, 10.1016/S0031-6997(25)00015-8 · DOI · Paper page
- 10.1007/BF00914025 · DOI
- 10.1523/JNEUROSCI.5273-08.2009 · DOI · Paper page
- 10.1074/jbc.M111.299248 · DOI · Paper page
- 10.1002/jnr.22779 · DOI · Paper page
- 10.1074/jbc.M111.330662 · DOI · Paper page
- 10.1074/jbc.M109.085464 · DOI · Paper page
- 10.1523/JNEUROSCI.2117-15.2016 · DOI · Paper page
- 10.1084/jem.180.4.1571 · DOI
- 10.1016/S0167-4838(00)00164-3 · DOI · Paper page
- 10.1136/jnnp.48.8.835 · doi:10.1136/jnnp.48.8.835
- 10.1083/jcb.85.3.890 · DOI · Paper page
- McManus, 1998, Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia, J Immunol, 160, 1449, 10.4049/jimmunol.160.3.1449 · DOI · Paper page
- 10.1523/JNEUROSCI.3696-05.2006 · DOI · Paper page
- 10.1023/A:1027342909423 · DOI
- 10.1097/00024382-200116030-00001 · DOI · Paper page
- 10.1111/j.1476-5381.2010.00659.x · DOI · Paper page
- 10.1002/eji.201242836 · DOI · Paper page
- 10.1007/BF00917452 · doi:10.1007/bf00917452
- 10.1016/S0166-2236(97)01139-9 · DOI · Paper page
- 10.1096/fj.01-0514fje · DOI · Paper page
- 10.1016/j.jchemneu.2005.07.003 · DOI · Paper page
- 10.1523/JNEUROSCI.1717-08.2008 · DOI · Paper page
- 10.1016/S0301-0082(98)00083-5 · DOI · Paper page
- 10.1007/s00401-006-0083-7 · DOI · Paper page
- 10.1038/200266a0 · DOI
- 10.1016/B978-0-12-398314-5.00004-0 · DOI · Paper page
- 10.4049/jimmunol.166.10.6383 · DOI · Paper page
- 10.1016/j.jneuroim.2006.11.014 · DOI · Paper page
- 10.1016/j.mvr.2012.05.003 · DOI
Cited by
Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation
Jha, M. K., Jo, M., Kim, J.-H., & Suk, K. (2019) · The Neuroscientist · doi:10.1177/1073858418783959 · Cited by 579
Self-citationSystemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome
Tejera, D., Mercan, D., Sanchez‐Caro, J. M., Hanan, M., Greenberg, D., Soreq, H., Latz, E., Golenbock, D., & Heneka, M. T. (2019) · The EMBO Journal · doi:10.15252/embj.2018101064 · Cited by 351
Neuron-Astrocyte Interactions in Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2020) · Cells · doi:10.3390/cells9122623 · Cited by 186
Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis
Zhou, B., Luo, Y., Ji, N., Hu, C., & Lu, Y. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00627-4 · Cited by 75
Dietary Restriction and Neuroinflammation: A Potential Mechanistic Link
Bok, E., Jo, M., Lee, S., Lee, B.-R., Kim, J., & Kim, H.-J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030464 · Cited by 53
“For instance, orosomucoid-2 (ORM2) derived from astrocytes effectively inhibited the proinflammatory activation of microglia via C-C chemokine ligand 4 (CCL4) during the late phase of neuroinflammation [80].”
BackgroundSelf-citation
Metadata
- Authors
- Jo, M., Kim, J.-H., Song, G. J., Seo, M., Hwang, E. M., & Suk, K.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2017-02-13
- Volume
- 37
- Issue
- 11
- Pages
- 2878-2894
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2588926033
- Cited by
- 180
- References
- 17
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation. https://app.cochat.ai/papers/10.1523/jneurosci.2534-16.2017
- The paper
- Jo, M., Kim, J.-H., Song, G. J., Seo, M., Hwang, E. M., & Suk, K. (2017). Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.2534-16.2017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.